New digital platform combines an 8-week Success Blueprint, Dr. Smith AI Wellness Coach, AI Agent-powered community support, and AI-powered Lifetime Wellness ModeNew digital platform combines an 8-week Success Blueprint, Dr. Smith AI Wellness Coach, AI Agent-powered community support, and AI-powered Lifetime Wellness Mode

Vynleads (OTCQB: VYND) Launches Done With Diabetes™ App, Bringing AI-Powered Daily Lifestyle Support to Blood Sugar and Metabolic Health

2026/02/12 04:15
Okuma süresi: 6 dk

New digital platform combines an 8-week Success Blueprint, Dr. Smith AI Wellness Coach, AI Agent-powered community support, and AI-powered Lifetime Wellness Mode to help users stay consistent beyond motivation

ROCK HILL, S.C.–(BUSINESS WIRE)–Vynleads (OTCQB: VYND) today announced the official launch of the Done With Diabetes™ app, a mobile-first digital wellness platform designed to help adults with type 2 diabetes, prediabetes, and metabolic health goals build sustainable lifestyle routines through clear daily structure, personalized guidance, and AI-powered wellness coaching.

For millions of people, diabetes is managed during brief clinical visits, yet outcomes are shaped by hundreds of daily decisions made at home, at work, and in everyday life. Done With Diabetes™ was built to close that gap by translating lifestyle medicine principles into a simple, repeatable day-by-day experience.

“We designed this platform for the reality of diabetes—it’s managed day by day,” said Alex Mannine, Co-Founder and CEO of Vynleads. “Done With Diabetes™ gives people a clear plan they can follow, with personalized guidance that adapts as they build momentum, plus a Community supported by AI Agents and peers so no one feels alone between appointments. The goal is simple: make progress sustainable.”

What Users Get Inside the Done With Diabetes™ App

The Done With Diabetes™ app is built around Vynleads’ proprietary Lifestyle Blueprint™. This AI-powered personalization engine aligns the program experience to each user’s goals, habits, and constraints. The result is a structured diabetes lifestyle routine that is designed to be used daily, not occasionally.

  • Lifestyle Blueprint™ Personalization: Tailors daily targets, habits, and focus areas, and continues adapting based on the user’s responses and actions throughout the 8-week program and into Vynleads’ Lifetime Wellness Mode to prevent habit regression.
  • 8-week Success Blueprint: A structured 56-day journey with phased modules (Foundation, Meal Plan, Lifestyle, Control) designed to build skills and routines progressively without the “you’re behind” pressure.
  • Dr. Smith AI Wellness Coach: Context-aware coaching that understands where a user is in the program and can help with meal swaps, real-world planning, motivation, and educational Q&A within clear wellness guardrails.
  • Diabetes-Friendly Meal Planning: A curated library of 43+ lower-calorie recipes with full nutrition data, shopping lists, and practical guidance to reduce decision fatigue.
  • Progress Tracking: Easy-to-use dashboards for lifestyle metrics such as energy, stress, sleep, hydration, movement, and habit completion, so progress stays visible.
  • Engagement Designed for Consistency: Points, streaks, a Daily Spin, leaderboards, and a Wellness Garden that visually reflects consistency and is specifically built to reinforce adherence over time.
  • Community Support and Accountability: Forums, victory sharing, weekly/monthly challenges, buddy matching, and mentorship pathways, plus AI Agents that respond to user posts and questions to help keep the community active, supportive, and welcoming.

AI Coaching and AI-Enhanced Community, Designed to Support Real Life

Dr. Smith functions as an always-available wellness coach who helps users turn education into action in the moments that matter, whether planning meals, navigating setbacks, or maintaining consistency when motivation declines. In the app’s Community section, a set of AI Agents can respond to questions, encourage progress, and point users to relevant lessons, daily missions, recipes, and challenges aligned with where they are in the program. These Agents also respond to one another to surface helpful perspectives and keep conversations moving within clear wellness-only guardrails, and with transparency controls so users can tailor how they engage.

AI-Powered Lifetime Wellness Mode: Support Beyond the First 8 Weeks

After the initial 56-day Success Blueprint, users transition into the AI-powered Lifetime Wellness Mode, an ongoing support experience designed for maintenance, relapse prevention, and long-term consistency. Instead of defaulting to generic recommendations, the app draws on each user’s responses and actions throughout the program, including onboarding inputs, mission completion, check-ins, and overall engagement.

It then uses that data to personalize what comes next, from weekly focus areas and post-graduation tasks to recommended missions, recipes, and challenges. The result is a frictionless continuation that keeps guidance relevant and actionable, helping reduce the “what now?” drop-off that often follows short-term programs.

A Scalable Digital Wellness Platform with a Subscription Model

For stakeholders, the launch represents a milestone in Vynleads’ evolution into a technology-enabled wellness platform. The Done With Diabetes™ app is launching as a subscription model—including a 7-day free trial and a $29/month subscription—designed to support recurring revenue while maintaining broad accessibility. The platform’s engagement loops (coaching, community, gamification, and post-graduation support) are intended to improve retention and lifetime value over time.

Vynleads’ long-term vision is to build an expanding “Done With (DWX)” family of condition-aware lifestyle programs on a single platform, leveraging the same Lifestyle Blueprint™ engine, AI coaching, and community framework to address additional lifestyle-driven health challenges. In parallel with the direct-to-consumer rollout, Vynleads plans to expand Done With Diabetes™ availability for enterprise partners that include self-insured employers, health plans and payers, healthcare systems and provider groups, and pharmacy benefit managers seeking scalable metabolic health support for the individuals they serve.

Important Notice

Done With Diabetes™ and the Done With Diabetes™ app are intended for general wellness and educational purposes only and are not intended to diagnose, treat, cure, or prevent any disease. Users should consult a qualified healthcare professional regarding any medical condition and before making changes to medications, diet, or exercise routines.

About Vynleads

Vynleads (OTCQB: VYND) is a wellness company focused on lifestyle-first programs designed to help consumers address chronic, lifestyle-driven health challenges. Beginning with Done With Diabetes™, the Company’s vision is to develop a portfolio of “Done With (DWX)” offerings that combine evidence-informed content, structured behavior change, and technology-enabled support. For more information, visit www.vynleads.com.

Forward-Looking Statements

This press release contains forward-looking statements made within the meaning of the Private Securities Litigation Reform Act of 1995 by Vynleads and its representatives. These statements can be identified by introductory words such as “expects,” “plans,” “intends,” “believes,” “will,” “estimates,” “forecasts,” “projects,” or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in reports filed by Vynleads with the Securities and Exchange Commission. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Vynleads undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts

Media Contact
Nick Mitsis
Percepture
[email protected]

Piyasa Fırsatı
RWAX Logosu
RWAX Fiyatı(APP)
$0.0001226
$0.0001226$0.0001226
-1.92%
USD
RWAX (APP) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

What SBI Really Owns in Ripple May Surprise XRP Investors

What SBI Really Owns in Ripple May Surprise XRP Investors

The post What SBI Really Owns in Ripple May Surprise XRP Investors appeared on BitcoinEthereumNews.com. SBI Holdings Chairman Yoshitaka Kitao has confirmed that
Paylaş
BitcoinEthereumNews2026/02/16 16:14
[Just Saying] ICC arrest warrant does not need local court imprimatur

[Just Saying] ICC arrest warrant does not need local court imprimatur

DUTERTE AT ICC. Former president Rodrigo Duterte during his first appearance before the International Criminal Court on March 14, 2025.
Paylaş
Rappler2026/02/16 16:00
ASML Shares Soar After Morgan Stanley Upgrade

ASML Shares Soar After Morgan Stanley Upgrade

The post ASML Shares Soar After Morgan Stanley Upgrade appeared on BitcoinEthereumNews.com. Morgan Stanley has upgraded ASML Holding NV to “Overweight” from “Equal-weight,” citing a favorable shift in the semiconductor industry driven by artificial intelligence (AI) and a cyclical recovery. The bank raised its price target for the Dutch chip equipment maker to €950 from €600, implying a potential 20% upside from its last closing price. Following the upgrade, ASML shares surged on Monday. According to UBS Group AG and Arete Research reports, Morgan Stanley, an American multinational investment bank and financial services firm, secured third position among firms to upgrade ASML’s stock in a month. Following the strong support system, reports dated September 22 revealed that ASML’s stock increased by up to 3.7%, reflecting a 33% increase, the highest record this year, compared to  September 2, which recorded a low point.  As a result of its tremendous success, ASML solidified its position as Europe’s largest publicly traded firm this month. This was after its valuation had skyrocketed to €322 billion, worth $379 billion, outperforming that of software company SAP SE and luxury brand LVMH. ASML’s strong support system vows to take its stock price to the highest level ever Nigel van Putten, Equity Research Analyst at Morgan Stanley, and Lee Simpson, Managing Director and Senior Equity Analyst at the firm, weighed in on the topic. In a note, they highlighted several growth opportunities extending into 2027, citing their decision to upgrade ASML to an “overweight” rating as an example. The analysts also projected that logic and memory chip maker advances will strengthen ASML’s business, positioning the company for gains over the next two years. Meanwhile, the Dutch chip giant’s upgrade has occurred swiftly, as reports reveal that recently, the firm that produces advanced chip equipment had encountered hardship in securing considerable gains from the demand for AI. Coincidentally, the upgrades from…
Paylaş
BitcoinEthereumNews2025/09/23 04:48